CorMedix (CRMD) Times Interest Earned (2012 - 2025)
CorMedix's (CRMD) quarterly Times Interest Earned came in at -$32.75 in Q4 2025, down 101.01% year-on-year from $3252.9 in Q4 2024, and down 160.48% quarter-over-quarter from $54.15 in Q3 2025.
CorMedix (CRMD) Times Interest Earned (2012 - 2025) Analysis & Trends
CorMedix has disclosed Times Interest Earned across 13 years of filings, most recently posting -$32.75 for Q4 2025.
- Times Interest Earned for Q4 2025 came in at -$32.75, down 101.01% year-over-year; the trailing twelve-month figure through Dec 2025 was $11.32 (up 110.05% YoY), and the FY2025 annual result was $11.32, up 110.05% from the prior year.
- Times Interest Earned came in at -$32.75 for Q4 2025 at CorMedix, down from $54.15 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $3252.9 in Q4 2024 to a low of -$2390.0 in Q4 2023.
- The 5-year median for Times Interest Earned is -$1255.4 (2023), against an average of -$652.19.
- Across the five-year window, Times Interest Earned tumbled 149.99% in 2023 and soared 236.11% in 2024, its largest moves.
- CorMedix's Times Interest Earned stood at -$1446.6 in 2021, then jumped by 33.91% to -$956.04 in 2022, then sank by 149.99% to -$2390.0 in 2023, then jumped by 236.11% to $3252.9 in 2024, then tumbled by 101.01% to -$32.75 in 2025.
- The last three Times Interest Earned figures came in at -$32.75 (Q4 2025), $54.15 (Q3 2025), and $2929.6 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -258.33 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 11.79 |
| 10 | CorMedix | 631,378.03 | -154.57 Mn | 107.31 Mn | -32.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -32.75 |
| Sep 30, 2025 | 54.15 |
| Jun 30, 2025 | 2,929.62 |
| Mar 31, 2025 | 2,011.12 |
| Dec 31, 2024 | 3,252.91 |
| Sep 30, 2024 | -328.50 |
| Jun 30, 2024 | -2,333.87 |
| Mar 31, 2024 | -1,698.45 |
| Dec 31, 2023 | -2,389.99 |
| Sep 30, 2023 | -798.24 |
| Jun 30, 2023 | -2,017.53 |
| Mar 31, 2023 | -1,255.38 |
| Dec 31, 2022 | -956.04 |
| Sep 30, 2022 | -793.29 |
| Jun 30, 2022 | -2,298.59 |
| Mar 31, 2022 | -1,307.62 |
| Dec 31, 2021 | -1,446.62 |
| Sep 30, 2021 | -1,591.70 |
| Mar 31, 2021 | -1,390.92 |
| Dec 31, 2020 | -1,143.30 |